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racteristically with leucocytosis, neutrophilia and
high ferritin, with absent reumatoid factor and an-
tinuclear antibodies. AOSD is considered the adult
correspondent of Systemic-Onset Juvenile Idiopa-
thic Arthritis (SOJIA). The original Still Disease des-
cribed by Sir George Frederick Still in 1897 affected
young persons. In children this disorder is included
in the group of Juvenile Idiopathic Arthritis2. 
The cause of AOSD is unknown. An infectious
cause has been postulated, although a definitive
agent has yet to be identified3. Agents such as ru-
bella, mumps, echovirus 7, cytomegalovirus, Ep-
stein-Barr virus, parainfluenza, coxsackievirus B4,
adenovirus, influenza A, human herpes virus 6, par-
vovirus B19, hepatitis B, hepatitis C, Mycoplasma
pneumoniae, Chlamydia pneumoniae, Yersinia en-
terocolitica 3 and 9, Brucella abortus and Borrelia
burgdoferi have all been implicated as triggers in
the pathogenesis of AOSD. A link with the presen-
ce of certain Human Leukocyte Antigens (HLA)
have been described also in patients with AOSD,
namely HLA-B17, HLA-B18, HLA-B35 and HLA-
-DR21.   Proinflammatory cytokines such as inter-
leukin (IL) 1, IL-6, IL-18, Interferon Gamma 
(IFN-γ), Tumor Necrosis Factor (TNF) and Macro-
phage Colony-Stimulating Factor (M-CSF) are ele-
vated in AOSD and are tough to have a major role
in pathogenesis4. It seems that the end result is a
global reactive syndrome with activation of ma-
crophage, natural-killer (NK) cells and B-lympho-
cytes, leading to a predominant cell-mediated im-
mune response. Diagnosis of AOSD is one of exclu-
sion, without specific clinical or laboratory anoma-
lies. The most widely accepted criteria set, as
presented by Yamaguchi and colleagues, is a com-
pilation of major and minor criteria with the exclu-
sion of infections, malignancies, and other rheu-
matic or systemic diseases (Table I)5. More recently,
Fautrel et al have proposed classification criteria
utilizing diagnostic markers of serum ferritin and
glycosylated ferritin, thought to be more specific for
AOSD6. Treatment of AOSD is often challenging.
Options consist of non-steroidal anti-inflamma-
Abstract
We present a case of a previously asymptomatic 34-
year-old man that presented to the emergency de-
partment with two weeks of fever, arthralgia of the
wrists and knees and sore throat. He was diagno-
sed with cytomegalovirus (CMV) mononucleosis.
The patient remained symptomatic in the 5 fol-
lowing months. After an extensive workup to exclu-
de other clinical conditions, a liver biopsy was per-
formed and CMV hepatitis was diagnosed. He star-
ted valganciclovir therapy. Approximately one year
after the initial complaints, the patient remained ill
and presented clinical criteria compatible with
Adult Onset Still´s Disease. The patient had a
marked improvement after institution of predni-
solone, an effect that has been sustained during
the following months. 
Keywords: Cytomegalovirus; Adult-onset Still Di-
sease; Cytotoxic Dysfunction. 
Introduction
Adult-Onset Still´s Disease (AOSD) is a systemic in-
flammatory disorder affecting mainly young adults.
It typically manifests as a triad of symptoms that in-
clude high-spiking fever, a characteristic rash and
arthralgias. Fever generally exceeds 39°C and is
transient, lasting typically less than 4 hours, and is
most commonly daily or twice-a-day in pattern,
with the highest temperatures seen in the late af-
ternoon or early evening1. Serum inflammatory
markers are elevated in laboratory analysis, cha-
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tory drugs, corticosteroids and other immunosup-
pressants or immunomodulatory drugs such as
methotrexate, gold, azathioprine, leflunomide,
cyclosporine and cyclosphosphamide, immuno-
globulin and cytokine inhibitors4.  
Cytomegalovirus (CMV) is a herpesvirus that
usually causes a mononucleosis syndrome in im-
munocompetent persons, presenting with fever,
leukopenia, relative lymphocytosis, lymphadeno-
pathy, hepatosplenomegaly and myalgia. It is a
common infection in all human populations and
a large percentage of healthy individuals (50-90%)
is chronically infected with the virus. In patients
with primary or acquired immunodeficiency, par-
ticular with depression of T-cell immunity, CMV
reactivation is associated with significant disease
in several organs and systems, such as lung, liver,
kidney, gastrointestinal tract, central nervous sys-
tem and heart7. Several immune disturbances are
described with primary CMV infection, like auto-
immune haemolytic anaemia and thrombocyto-
penia, vasculitis and hypogammaglobulinaemia8.
In immunocompetent individuals, it is generally
assumed that viral replication is suppressed predo-
minantly, but not exclusively, by CD8+ T-cell. A ma-
jor expansion of specific IFN-γ secreting CD4+ T-
cells is now being recognized being associated with
primary CMV infection. In acute state, the peak of
IFN-γ secreting CD4+ T-cells appears 10 days  after
CMV DNA is detectable, being followed, 7 days la-
ter, by the appearance of immunoglobulin M and
immunoglobulin G and, 14 days later, by the
appearance of CMV-specific CD8+ T-cells. It seems
that both T-cell subtypes must be present to con-
trol viral replication and recovery from infection9.
Primary CMV infection generally doesn’t need any
treatment. However, CMV reactivation in immuno-
supressed persons with end-organ disease needs
pharmacological treatment with drugs that block
viral DNA polymerase, such as ganciclovir, valgan-
ciclovir, foscarnet and cidofovir7. 
Case Report  
In June 2007 a previously asymptomatic 34-year-
-old man presented to the emergency department
with two weeks of fever, arthralgia of the wrists and
knees and sore throat. After one week of an empiri-
cally treatment course with amoxicillin-clavulana-
te (875/125 mg b.i.d) he also experienced a self-li-
mited morbilliform rash. His past history was
marked by a Wolf-Parkinson-White Syndrome de-
tected in his youth, treated with ablation of the car-
diac accessory pathway. He denied any recent drug
exposure or travel.  On admission he exhibited a
39ºC tympanic temperature, cervical adenopathies
and mild splenomegaly. The remaining physical
examination was unremarkable. Analysis showed
leukocytosis (14.400 cell/mm3), absolute and rela-
tive lymphocytosis with atypical forms, C-reactive
protein 3.53 mg/dL and Erythrocyte Sedimentation
Rate (ESR) 21 mm/1sth. There was a slight elevation
of transaminases (x 0.5 normal) and a positive CMV
Table I. Time evolution of laboratory results
June December February June
Result/Date 2007 2007 2008 2008
White Cells (cell/mm3) 14.400 18.500 16.440 23.000
Neutrophils (%) 42 79 88 90
Lymphocytes (%) 46 25 29 20
AST (U/L) 70 150 112 40
IgM CMV (UA/ml)1 + + + –
Ferritin (ng/ml) 500 1.556 NR2 6.400
Immunoglobulins3
IgA 235 171 31 150
IgM 306 113 24 300
IgG 769 729 458 660
1 Enzyme immunoassay (ElA). Cutt-off value for positive test is 1.20 UA/ml.
2 Values not registered.
3 Normal values (IgA 50 – 400 mg/dl, IgM 50 – 300 mg/dl, IgG600 – 1500 mg/dl.
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cell/µL (57%), a low CD19+ B-cell count and a nor-
mal CD16+ NK-cell count (141 cell/µl, 7%). IgA, IgG
and IgM levels were low (Table I). Tetanus and pneu-
mococcal vaccination resulted in antibody respon-
se, excluding Common Variable Immunodeficiency.
In June 2008 he maintained fever and arthral-
gia of the wrists. He also complained of a light ge-
neralized myalgia, predominantly in the cervical
muscles. The wrists were found to be painful to
palpation, without erythema or edema. Analysis
registered leukocytosis (23.000 cell/mm3) with 90%
neutrophils, ESR 77 mm/h and ferritin 6400 ng/mL
(Table I). CMV IgM was negative, liver enzymes
and immunoglobulins levels were normal. Adult-
-Onset Still´s Disease was suspected because the
patient had clinical and laboratory criteria consis-
tent with Yamaguchi criteria for AOSD (Table I and
II). The patient started naproxen 500 mg b.i.d. 
After two weeks of this therapy, he experienced
only a partial improvement of symptoms.  His
treatment was changed to prednisone 1mg/kg/
/day. There was a marked improvement after ins-
titution of this therapy, sustained over the following
weeks. Prednisolone was tapered during 3 months
to 5 mg q.d, and then were added to the treatment
regimen methotrexate (20 mg/week) and naproxen
(1 g q.d). The patient has been remained clinically
stable with this therapy until the present day. 
Discussion
Clinical associations between AOSD and CMV in-
fectioncan been found in the literature1,10.  Immu-
IgM and IgG titters (Enzyme immunoassay, cut-off
for positive values > 1.2 UA/mL). The search for Hbs
and p24 antigens and antibodies against HIV, 
HCV, HAV, EBV, Toxoplasma gondii and Strep-
tolysin-O was negative. CMV-induced mononucle-
osis syndrome was assumed, and the patient was
discharged with acetominophen.   
He eventually remained symptomatic in the
following months. In October 2007, analytical eva-
luation showed a persistent leucocytosis, hepati-
tis (transaminases x 1.5 normal) and high CMV
IgM. A liver biopsy was performed. Histological
sections in hematoxilin/eosin identified epithe-
lioid granulomas, portal inflammation, nuclear
and cytoplasmic inclusions in hepatocytes and
Kupfer cells. Immunohistochemistry was compa-
tible with CMV infection (Figure 1). He was started
on valganciclovir (900 mg b.i.d). However, after 21
days of therapy, fever remained intermittently. 
In February 2008 he maintained elevated titters
of CMV IgM and liver enzymes. Cultures of periphe-
ral blood and antibodies to other agents such as
Brucella spp, Borrelia spp and Coxiella burnetii were
negative. Bone marrow aspirate showed only gene-
ralized hyperreactivity without other abnormalities
in the main cellular lineages. The culture of blood
marrow was negative. Echocardiogram, body com-
puterized tomography scan and upper and lower
gastrointestinal endoscopy were normal. Markers
for autoimmune/inflammatory diseases such as
ANA, ANCA and rheumatoid factors and tumor
markers were also negative. Cytometry showed an
inversed TCD4+/TCD8+ ratio (ratio 0.52), with
CD4+ T-cells 648 cell/µL (30%) and CD8+ T-cell 1240
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nologically, both entities can present abnormali-
ties involving T-cytotoxic dysfunction and high
production of IFN-γ. Both are capable of inducing
an excessive activation and proliferation of T-cells
and macrophages, leading to an overwhelming
systemic inflammatory response. 
A paradigm of this kind of reaction is the Ma-
crophage Activation Syndrome (MAS, also called
Reactive Hemophagocytic Syndrome), an immu-
ne “overreaction” that can occur both in patients
with AOSD and herpesvirus infection, particular
Epstein-Barr virus and CMV. This syndrome was
also reported in a patient that was diagnosed si-
multaneously with a CMV infection and AOSD11,12.
It is a rare and life-threatening disease characteri-
zed by a generalized macrophage phagocytosing of
hematopoietic elements, and that usually presents
with fever, lymphadenopathy, hepatosplenome-
galy, liver dysfunction and coagulopathy.  It is now
increasingly recognized that MAS bears close re-
semblance to other closed disorder, Secondary Ha-
emophagocytic Lymphohistiocytosis (HLH), a bet-
ter-defined entity seen in a heterogeneous group
of diseases including infections, neoplasms, hae-
matological conditions and autoimmune di-
sorders.  
An immunological link approach MAS, HLH,
AOSD, SOJIA and some complicated CMV/other
herpesvirus infections: NK and cytotoxic CD8+ T-
-lymphocyte dysfunction. First, patients with vi-
rus-associated HLH showed a very low or absent
NK cytolytic activity. Second, it was demonstrated
that a quantitative and/or qualitative dysfunction
in NK cells result in exaggerated immune respon-
se to CMV. In the murine model this leads to expan-
sion of CD8+ T-cell that secrete IFN-γ, an impor-
tant macrophage and inflammatory activator.
Third, it was also proved that CMV has evolved eva-
sion mechanisms to down-regulate or sequester
Major Histocompatibility Complex (MHC) mole-
cules, important signals for CD8+ T-cells. This ser-
ves as an activating signal for NK cells that trigger
their cytolytic activity. It was hypothesised that, af-
ter and infection with an agent like CMV in a sus-
ceptible host, a fail to kill infected cells and thus,
fails to remove antigenic stimulation, leads to a
persistent antigen-driven activation and prolife-
ration of T-cells that will cause an escalating cytoki-
ne production, leading to macrophage activation13. 
In summary, the authors hypothesized that the
combination of genetic susceptibility of the host
(possibly a qualitative dysfunction in NK cells
and/or general cytotoxic immune status) and a
specific viral aggression (CMV infection), produced
an aberrant immune response that lead to a chro-
nic inflammatory disorder, AOSD.  
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